Exact Sciences fell over 2% premarket Thursday, even as William Blair said any Abbott takeover would likely exceed $100 per share, far above its recent range. The stock had surged 24% on Wednesday after reports that Abbott is exploring a deal to expand its diagnostics portfolio. Abbott shares slipped nearly 3% amid speculation over the potential acquisition.